A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer

NCT06978114 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Biliary Tract Cancer

Interventions

DRUG: BL-B01D1
DRUG: Pembrolizumab

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]